Prognostic relevance of integrated genetic profiling in acute myeloid leukemia (Q27851726)

PubMed publication ID

22417203

13 November 2016

title

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia (English)

1 reference

PubMed publication ID

13 November 2016

1 reference

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author

Pieter Van Vlierberghe

7

Pieter Van Vlierberghe

0 references

Mithat Gönen

2

Mithat Gönen

0 references

Martin S. Tallman

28

Martin S Tallman

0 references

Elisabeth Paietta

27

Elisabeth Paietta

0 references

Hillard M. Lazarus

23

Hillard M Lazarus

0 references

Gail H. Vance

17

Gail Vance

0 references

Athena Cherry

16

Athena Cherry

0 references

Selina Luger

25

Selina Luger

0 references

Mark R Litzow

21

Mark Litzow

0 references

Omar Abdel-Wahab

Omar Abdel-Wahab

30

1 reference

ORCID Public Data File 2021

Marcel R.M. van den Brink

22

Marcel R M van den Brink

0 references

author name string

Jay P Patel

1

0 references

Maria E Figueroa

3

0 references

Hugo Fernandez

4

0 references

Zhuoxin Sun

5

0 references

Janis Racevskis

6

0 references

Igor Dolgalev

8

0 references

Sabrena Thomas

9

0 references

Olga Aminova

10

0 references

Kety Huberman

11

0 references

Janice Cheng

12

0 references

Agnes Viale

13

0 references

Nicholas D Socci

14

0 references

Adriana Heguy

15

0 references

Rodney R Higgins

18

0 references

Rhett P Ketterling

19

0 references

Robert E Gallagher

20

0 references

Jacob M Rowe

24

0 references

Adolfo Ferrando

26

0 references

Ari Melnick

29

0 references

Ross L Levine

The New England Journal of Medicine

31

0 references

language of work or name

English

0 references

publication date

22 March 2012

0 references

published in

1 reference

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

volume

366

0 references

issue

12

0 references

page(s)

1079-89

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

DNMT3A Mutations in Acute Myeloid Leukemia

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Recurring mutations found by sequencing an acute myeloid leukemia genome

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Mutation in TET2 in myeloid cancers

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

PHF6 mutations in adult acute myeloid leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Anthracycline dose intensification in acute myeloid leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

High-dose daunorubicin in older patients with acute myeloid leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Prognostically useful gene-expression profiles in acute myeloid leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545649

Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics

27 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22417203